Menarini Industrie Farmaceutiche Riunite | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Headlines Articles Press releases Menarini Industrie Farmaceutiche Riunite

Home
Companies
Menarini Industrie Farmaceutiche Riunite

BRIEF

published on 11/24/2025 at 16:35, 10 days 12 hours ago

Menarini Group Unveils New ELZONRIS® Data at Hematology Meeting

Oncology Menarini ELZONRIS BPDCN Hematology
PRESS RELEASE

published on 11/24/2025 at 16:30, 10 days 12 hours ago

Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition
Menarini Group and Stemline Therapeutics to present new data on ELZONRIS at ASH Annual Meeting. Data includes triplet therapy results for BPDCN patients

ASH Annual Meeting Menarini Group ELZONRIS BPDCN Stemline Therapeutics
BRIEF

published on 11/24/2025 at 15:35, 10 days 13 hours ago

The Volpi Rosse Menarini: Ready for the 2025-2026 Season

Wheelchair Basketball Volpi Rosse Menarini Eurocup 3 Menarini Group Sports Inclusion
PRESS RELEASE

published on 11/24/2025 at 15:30, 10 days 13 hours ago

The Volpi Rosse Menarini: The 'Fantastic Ten' are ready for the 2025 - 2026 Season
Italian wheelchair basketball team, sponsored by Menarini, presented the new roster for the 2025/2026 season, aiming for success in Serie A and Eurocup 3

Série A 2025/2026 Season Wheelchair Basketball Eurocup 3 Menarini

Accesswire

Published on 12/05/2025 at 02:35, 2 hours 46 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 2 hours 51 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 4 hours 21 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 16 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 21 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 1 hour 51 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 30 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 56 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 6 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 11 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 11 hours 21 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 36 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 37 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 20 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE